Trials / Completed
CompletedNCT01331447
Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
A Pilot Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | exemestane | 25 mg tablet |
Timeline
- Start date
- 2004-05-01
- Primary completion
- 2004-05-01
- Completion
- 2004-05-01
- First posted
- 2011-04-08
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01331447. Inclusion in this directory is not an endorsement.